142 related articles for article (PubMed ID: 1299229)
1. Elliptic Fourier analysis of megakaryocyte nuclei in chronic myeloproliferative disorders.
Nafe R; Kaloutsi V; Choritz H; Georgii A
Anal Quant Cytol Histol; 1992 Oct; 14(5):391-7. PubMed ID: 1299229
[TBL] [Abstract][Full Text] [Related]
2. [Morphometry of megakaryocytes for supporting the histologic diagnosis of chronic myeloproliferative diseases].
Nafe R; Holgado de Colombo S; Choritz H; Georgii A
Pathologe; 1995 Jan; 16(1):34-40. PubMed ID: 7886012
[TBL] [Abstract][Full Text] [Related]
3. Planimetric analysis of megakaryocytes in the four main groups of chronic myeloproliferative disorders.
Nafe R; Georgii A; Kaloutsi V; Fritsch RS; Choritz H
Virchows Arch B Cell Pathol Incl Mol Pathol; 1991; 61(2):111-6. PubMed ID: 1683718
[TBL] [Abstract][Full Text] [Related]
4. [Diagnosis of chronic myeloproliferative diseases based on bone marrow biopsy].
Matolcsy A; Kónya T; Wéber E
Orv Hetil; 1992 Jun; 133(26):1617-20, 1625-6. PubMed ID: 1614699
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow biopsy (BMB). II. Bone marrow biopsy in myeloproliferative disorders.
Macavei I; Galatâr N
Morphol Embryol (Bucur); 1989; 35(2):117-27. PubMed ID: 2529429
[TBL] [Abstract][Full Text] [Related]
6. Myelofibrosis in chronic myeloproliferative disorders. Incidence among subtypes according to the Hannover Classification.
Buhr T; Georgii A; Choritz H
Pathol Res Pract; 1993 Mar; 189(2):121-32. PubMed ID: 8321741
[TBL] [Abstract][Full Text] [Related]
7. Chronic myeloproliferative disorders (CMPD).
Burkhardt R; Bartl R; Jäger K; Frisch B; Kettner G; Mahl G; Sund M
Pathol Res Pract; 1984 Nov; 179(2):131-86. PubMed ID: 6395125
[TBL] [Abstract][Full Text] [Related]
8. Objective, planimetry-based assessment of megakaryocyte histological pictures in Philadelphia-chromosome-negative chronic myeloproliferative disorders: a perspective for a valuable adjunct diagnostic tool.
Rudzki Z; Kawa R; Okoñ K; Szczygieł E; Stachura J
Virchows Arch; 2006 Jan; 448(1):59-67. PubMed ID: 16220296
[TBL] [Abstract][Full Text] [Related]
9. Nucleolar organizer regions of megakaryocytes in chronic myeloproliferative disorders.
Matolcsy A; Nádor R; Wéber E; Kónya T
Virchows Arch A Pathol Anat Histopathol; 1992; 420(5):441-5. PubMed ID: 1375798
[TBL] [Abstract][Full Text] [Related]
10. [LAT (linker for activation of T cells): a useful marker for megakaryocyte evaluation on bone marrow biopsies].
Ungari M; Pellegrini W; Borlenghi E; Marocolo D; Ubiali A; Agazzi C; Pich A; Franco V; Facchetti F
Pathologica; 2002 Dec; 94(6):325-30. PubMed ID: 12540999
[TBL] [Abstract][Full Text] [Related]
11. Megakaryopoiesis in chronic myeloproliferative diseases. A morphometric evaluation with special emphasis on primary thrombocythemia.
Thiele J; Funke S; Holgado S; Choritz H; Georgii A
Anal Quant Cytol; 1984 Sep; 6(3):155-67. PubMed ID: 6594964
[TBL] [Abstract][Full Text] [Related]
12. Megakaryocyte markers in myeloproliferative disorders.
Iványi JL; Kiss A; Telek B; Tornai I
Acta Histochem; 1993 Sep; 95(1):79-88. PubMed ID: 7506475
[TBL] [Abstract][Full Text] [Related]
13. Quantitative cytomorphology of megakaryocytes in chronic myeloproliferative disorders--analysis of planimetric and numeric characteristics by means of a knowledge based system.
Nafe R; Kaloutsi V; Fritsch RS; Georgii A
Exp Pathol; 1990; 40(4):213-9. PubMed ID: 2098268
[TBL] [Abstract][Full Text] [Related]
14. Density distribution and size of megakaryocytes in inflammatory reactions of the bone marrow (myelitis) and chronic myeloproliferative diseases.
Thiele J; Holgado S; Choritz H; Georgii A
Scand J Haematol; 1983 Oct; 31(4):329-41. PubMed ID: 6578591
[TBL] [Abstract][Full Text] [Related]
15. Megakaryocytic features useful for the diagnosis of myeloproliferative disorders can be obtained by a novel unsupervised software analysis.
Tripodo C; Valenti C; Ballarò B; Rudzki Z; Tegolo D; Di Gesù V; Florena AM; Franco V
Histol Histopathol; 2006 Aug; 21(8):813-21. PubMed ID: 16691533
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic value of bone marrow biopsy in chronic myeloproliferative disorders].
Bettini R; Marzetta K; Miglioranza A; Redaelli S; Maino C; Maffiolini A; Gorini M
Recenti Prog Med; 2003; 94(7-8):314-20. PubMed ID: 12868237
[TBL] [Abstract][Full Text] [Related]
17. Is it chronic idiopathic myelofibrosis, myelofibrosis with myeloid metaplasia, chronic megakaryocytic-granulocytic myelosis, or chronic megakaryocytic leukemia? Further thoughts on the nosology of the clonal myeloid disorders.
Lichtman MA
Leukemia; 2005 Jul; 19(7):1139-41. PubMed ID: 15902283
[No Abstract] [Full Text] [Related]
18. [Jamshidi biopsy in clinical hematology. Method, indications and results of over 1,000 completed biopsies with special reference to chronic myeloproliferative diseases].
Seewann HL
Wien Med Wochenschr Suppl; 1986; 100():1-24. PubMed ID: 3471009
[TBL] [Abstract][Full Text] [Related]
19. [Histological diagnosis of Ph-negative myeloproliferative neoplasia. An overview].
Campr V
Cesk Patol; 2011 Jul; 47(3):84-93. PubMed ID: 21887923
[TBL] [Abstract][Full Text] [Related]
20. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
